Personal care product exposures and survivorship: the breast cancer survivors intervention protocol
Abstract
IntroductionBlack breast cancer survivors are concerned about endocrine disrupting chemicals (EDCs) in personal care products in the context of their quality of life (QOL) journey. Exposures to these chemicals have been associated with breast cancer risk, tumor grade, and size due to their estrogenic effects. However, current health behavior guidelines do not include interventions to reduce these exposures. The Breast Cancer Survivors Intervention (BCSI, Clinical Trials ID: NCT06885203) was developed to address Black women’s unique QOL needs related to identity, and an emerging environmental risk.MethodsThis study is a hybrid type 1 efficacy-implementation design using a waitlist control to determine the preliminary efficacy of the BCSI. BCSI is a 6-week peer-led QOL intervention that includes education on personal care product exposure reduction. The online synchronous intervention is supported by a learning management system (e.g., LearnWorlds), Clearya Survey—a mobile application data collection tool, 14-day product substitution, and longitudinal biospecimen collection. Eligible participants (N = 40) are individuals who meet the following criteria: (1) adult woman aged 18 years and older; (2) histologically confirmed stage 0-III breast cancer; (3) no evidence of local recurrence or metastatic disease; (4) self-identify as Black; and (5) able to communicate in English. The main study outcomes include: QOL, health behavior, and exposure assessments. Implementation will be evaluated using a mixed methods approach, including fidelity, feasibility, acceptability, and actual fit at the participant, deliverer (peer leader), and organizational levels.DiscussionBCSI is a peer-led QOL intervention for breast cancer survivors that includes education and behavioral strategies to reduce potentially harmful chemical exposures from personal care products. Findings from this study could support culturally responsive health behavior strategies that improve survivorship experiences while reducing exposure-related concerns among Black women.Clinical trials registrationClinical Trials ID: NCT06885203, https://clinicaltrials.gov/study/NCT06885203?term=NCT06885203&rank=1.
Related
- An adapted enhanced social prescribing intervention vs. usual care in the treatment of loneliness in cancer survivors: Study protocol for a feasibility pilot randomized controlled trial
- Comparative Assessment of Personal Exposures to Environmental Contaminants Using Silicone Wristbands and Fresh Air Wristbands.
- Barriers to survivorship care for adolescent and young adult cancer survivors: perspectives of survivors and cancer specialists
- Financial concerns: a critical gap in survivors’ experience of the implementation of the national standards for cancer survivorship care
- Characterizing Preschool Children's Multi-Matrix Air Pollutant Exposures Across Home and Early Childhood Education Settings: A Paired Silicone Wristband Study Protocol
BibTeX
@article{tetehbrooks2026personal,
title = {{Personal care product exposures and survivorship: the breast cancer survivors intervention protocol}},
author = {Dede K. Teteh-Brooks and Pastor Rhonda Holbert and Tiah Tomlin-Harris and Virginia Sun and Abenaa Brewster and Robert Newton and Robin E. Dodson and Lorna McNeill and Minxing Chen and Lin Tan and Loren Bryant and Jaquelin Hernandez and Derek Broome and Jenna Hua and Oren Agiv and Tamar Golovenzitz and Amit Rosner and Adana A. M. Llanos and Laura M. Glynn},
journal = {Frontiers in Public Health},
year = {2026},
month = nov,
doi = {10.3389/fpubh.2026.1967491},
url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1967491},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Personal care product exposures and survivorship: the breast cancer survivors intervention protocol
AU - Dede K. Teteh-Brooks
AU - Pastor Rhonda Holbert
AU - Tiah Tomlin-Harris
AU - Virginia Sun
AU - Abenaa Brewster
AU - Robert Newton
AU - Robin E. Dodson
AU - Lorna McNeill
AU - Minxing Chen
AU - Lin Tan
AU - Loren Bryant
AU - Jaquelin Hernandez
AU - Derek Broome
AU - Jenna Hua
AU - Oren Agiv
AU - Tamar Golovenzitz
AU - Amit Rosner
AU - Adana A. M. Llanos
AU - Laura M. Glynn
PY - 2026
DA - 2026/11/03
JO - Frontiers in Public Health
DO - 10.3389/fpubh.2026.1967491
UR - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1967491
AB - IntroductionBlack breast cancer survivors are concerned about endocrine disrupting chemicals (EDCs) in personal care products in the context of their quality of life (QOL) journey. Exposures to these chemicals have been associated with breast cancer risk, tumor grade, and size due to their estrogenic effects. However, current health behavior guidelines do not include interventions to reduce these exposures. The Breast Cancer Survivors Intervention (BCSI, Clinical Trials ID: NCT06885203) was developed to address Black women’s unique QOL needs related to identity, and an emerging environmental risk.MethodsThis study is a hybrid type 1 efficacy-implementation design using a waitlist control to determine the preliminary efficacy of the BCSI. BCSI is a 6-week peer-led QOL intervention that includes education on personal care product exposure reduction. The online synchronous intervention is supported by a learning management system (e.g., LearnWorlds), Clearya Survey—a mobile application data collection tool, 14-day product substitution, and longitudinal biospecimen collection. Eligible participants (N = 40) are individuals who meet the following criteria: (1) adult woman aged 18 years and older; (2) histologically confirmed stage 0-III breast cancer; (3) no evidence of local recurrence or metastatic disease; (4) self-identify as Black; and (5) able to communicate in English. The main study outcomes include: QOL, health behavior, and exposure assessments. Implementation will be evaluated using a mixed methods approach, including fidelity, feasibility, acceptability, and actual fit at the participant, deliverer (peer leader), and organizational levels.DiscussionBCSI is a peer-led QOL intervention for breast cancer survivors that includes education and behavioral strategies to reduce potentially harmful chemical exposures from personal care products. Findings from this study could support culturally responsive health behavior strategies that improve survivorship experiences while reducing exposure-related concerns among Black women.Clinical trials registrationClinical Trials ID: NCT06885203, https://clinicaltrials.gov/study/NCT06885203?term=NCT06885203&rank=1.
SN - 2296-2565
ER -